Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma
Open accessAbstract
The effect of genetic polymorphisms for glutathione S-transferase ( GST) M1, GSTT1, GSTP1-1( GSTP1), cytochrome P450 2E1 ( CYP2E1) and aldehyde dehydrogenase 2 ( ALDH2) on the risk of hepatocellular carcinoma (HCC) was observed in 78 Japanese patients with HCC and 138 non-cancer hospital controls. We found a positive association between cumulative amounts of alcohol consumption (>/=600,000 ml in a lifetime) and the risk of HCC (OR=4.52, 95% CI 2.39-8.55). However, cigarette smoking was not significantly related to the risk of HCC (OR=1.23, 95% CI 0.57-2.68). The allelic frequencies of GSTM1, GSTT1, GSTP1, CYP2E1and ALDH2of HCC patients were not significantly different from those of controls when odds ratios were only adjusted for age and gender except for any 2 alleles of ALDH2in drinkers (OR=2.53, 95% CI 1.21-5.31). However, the frequency of any C2 alleles of CYP2E1and any 2 alleles of ALDH2were significantly higher than those of controls (OR=5.77, 95% CI 1.24-27.39, OR=9.77, 95% CI 1.63-58.60) when covariates including viremia were selected by using stepwise logistic regression analysis. We conclude that habitual alcohol drinking is likely to lead to an increased risk of HCC, and any C2alleles of CYP2E1as well as any two alleles of ALDH2were also associated with an increased risk of HCC.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
ALDH2*2 allele is associated with a high incidence of liver cancer in heavy drinkers.
“The ALDH2 mutant genotype, ALDH2*2 allele (also known as ALDH2(E487K) or ALDH2 rs671 polymorphism), has been found to be associated with a high incidence of liver cancer in heavy drinkers [118,119,120].”
From Pathophysiological Aspects of Alcohol Metabolism in the Liver (2021) · cites this paper as [118]
Cited by
Sorted by citations
Hepatocellular carcinoma in the setting of alcohol-related liver disease
Ganne-Carrié, N., & Nahon, P. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.10.008 · Cited by 360 · see citing works
Acetaldehyde adducts in alcoholic liver disease
Setshedi, M., Wands, J. R., & de la Monte, S. M. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.3.12288 · Cited by 365 · see citing works
Pathophysiological Aspects of Alcohol Metabolism in the Liver
Hyun, J., Han, J., Lee, C., Yoon, M., & Jung, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115717 · Cited by 324 · see citing works
Seo, W., Gao, Y., He, Y., Sun, J., Xu, H., Feng, D., Park, S. H., Cho, Y.-E., Guillot, A., Ren, T., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.06.018 · Cited by 218 · see citing works
Abdel-Rahman, O., Helbling, D., Schöb, O., Eltobgy, M., Mohamed, H., Schmidt, J., giryes, A., Mehrabi, A., Iype, S., John, H., et al. (2017) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12270 · Cited by 118 · see citing works
Alcohol and hepatocellular carcinoma
Matsushita, H., & Takaki, A. (2019) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2018-000260 · Cited by 110 · see citing works
Sakamoto, T., Hara, M., Higaki, Y., Ichiba, M., Horita, M., Mizuta, T., Eguchi, Y., Yasutake, T., Ozaki, I., Yamamoto, K., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.21505 · Cited by 88 · see citing works
- Authors
- Munaka, M., Kohshi, K., Kawamoto, T., Takasawa, S., Nagata, N., Itoh, H., Oda, S., & Katoh, T.
- Affiliations
- Nissan (Japan) (JP)
- University of Occupational and Environmental Health Japan (JP)
- University of Miyazaki (JP)
- Corresponding author
- Katoh, Takahiko
- Venue
- Journal of Cancer Research and Clinical Oncology
- Published
- 2003-06-01
- Volume
- 129
- Issue
- 6
- Pages
- 355-360
- ISSN
- 0084-5353 (ISSN-L)
- 0171-5216
- 1432-1335
- PMC
- PMC12162083
- OpenAlex
- W2064057901
- Cited by
- 132
- References
- 0
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 2 · 2023: 4 · 2022: 3 · 2021: 4 · 2020: 3 · 2019: 7 · 2018: 3 · 2017: 4 · 2016: 8 · 2015: 13 · 2014: 6 · 2013: 4 · 2012: 14
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Cancer Research and Clinical Oncology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glutathione Transferases and Polymorphisms
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- hepatocellular carcinoma, genetic polymorphism, alcohol consumption, cigarette smoking, glutathione S-transferase, GSTM1, GSTT1, GSTP1, CYP2E1, ALDH2, Japanese patients, viremia
- MeSH terms
- Aldehyde Dehydrogenase, Mitochondrial, Adult, Aged, Aged, 80 and over, Alcohol Drinking, Aldehyde Dehydrogenase, Female, Glutathione Transferase, Carcinoma, Hepatocellular, Humans, Liver Neoplasms, Male, Middle Aged, Polymorphism, Genetic, Risk Factors, Smoking, Cytochrome P-450 CYP2E1, Genetic Predisposition to Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review